146 related articles for article (PubMed ID: 6395678)
21. Intracellular fate of Mycobacterium leprae in cultured murine macrophages in 24-well trays.
Osawa N
Kitasato Arch Exp Med; 1991 Dec; 64(4):213-20. PubMed ID: 1823921
[TBL] [Abstract][Full Text] [Related]
22. [Multiplication of Mycobacterium leprae in the mouse foot-pad. 1. Thermoresistance of Mycobacterium leprae].
Nakabayashi S
Nihon Saikingaku Zasshi; 1970 Feb; 25(2):104-11. PubMed ID: 4910146
[No Abstract] [Full Text] [Related]
23. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
Levy L; Ji B
Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
[TBL] [Abstract][Full Text] [Related]
24. Accelerated mortality in young NZB/NZW mice treated with the interferon inducer tilorone hydrochloride.
Walker SE
Clin Immunol Immunopathol; 1977 Sep; 8(2):204-12. PubMed ID: 902437
[No Abstract] [Full Text] [Related]
25. Effect of tilorone treatment on intracellular microbial infections in specific-pathogen-free mice.
Collins FM
Antimicrob Agents Chemother; 1975 Apr; 7(4):447-52. PubMed ID: 125066
[TBL] [Abstract][Full Text] [Related]
26. Multiplication of Mycobacterium leprae in the nude mouse, and some applications of nude mice to experimental leprosy.
McDermott-Lancaster RD; Ito T; Kohsaka K; Guelpa-Lauras CC; Grosset JH
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):889-95. PubMed ID: 3325583
[TBL] [Abstract][Full Text] [Related]
27. Use of cycloheximide on intracellular growth of Mycobacterium leprae in cultured murine macrophages.
Osawa N
Kitasato Arch Exp Med; 1991 Dec; 64(4):205-12. PubMed ID: 1823920
[TBL] [Abstract][Full Text] [Related]
28. Superinfection in mice previously infected with Mycobacterium leprae.
Levy L
Infect Immun; 1975 May; 11(5):1094-9. PubMed ID: 1091561
[TBL] [Abstract][Full Text] [Related]
29. Experimental mycobacterial infections of CBA/N mice.
Levy L; Aizer F; Bejar C; Lutsky I; Mor N
Isr J Med Sci; 1984 Jul; 20(7):598-602. PubMed ID: 6381393
[TBL] [Abstract][Full Text] [Related]
30. Some characteristics of the action of dapsone on multiplication of Mycobacterium leprae in the mouse.
Levy L; Peters JH
Lepr Rev; 1977 Dec; 48(4):237-45. PubMed ID: 400808
[No Abstract] [Full Text] [Related]
31. Regulation of a microsomal protein kinase from mouse liver by hemin and the interferon inducer tilorone.
Pierre M; Loeb JE
Biochem Biophys Res Commun; 1977 Jul; 77(2):481-8. PubMed ID: 901481
[No Abstract] [Full Text] [Related]
32. Comparation interferon- inducing and antiviral properties of 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), tilorone hydrochloride, and polyinosinic-polycytidylic acid.
Stringfellow DA
Antimicrob Agents Chemother; 1977 Jun; 11(6):984-92. PubMed ID: 879763
[TBL] [Abstract][Full Text] [Related]
33. Effect of the immunomodulator tilorone on the in vivo acetylation of procainamide in the rat.
Svensson CK; Knowlton PW
Pharm Res; 1989 Jun; 6(6):477-80. PubMed ID: 2474808
[TBL] [Abstract][Full Text] [Related]
34. Effect of the immunomodulator tilorone on antipyrine disposition in the rat.
Svensson CK
J Pharm Sci; 1986 Oct; 75(10):946-8. PubMed ID: 3795024
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of multiplication of Mycobacterium leprae in mouse foot pads by immunization with ribosomal fraction and culture filtrate from Mycobacterium bovis BCG.
Matsuoka M; Nomaguchi H; Yukitake H; Ohara N; Matsumoto S; Mise K; Yamada T
Vaccine; 1997 Aug; 15(11):1214-7. PubMed ID: 9286046
[TBL] [Abstract][Full Text] [Related]
36. Comparison of interferon-inducing activities and antiviral effects of tobacco mosaic virus, tilorone and sodium nucleinate.
Balezina TI; Korneeva LE; Zemskov VM; Loidina GI; Nikolaeva OV; Fainshtein SL; Fadeeva LL; Eromolieva ZV
Acta Virol; 1977 Jul; 21(4):338-43. PubMed ID: 20769
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the ability of small molecular interferon inducers: tilorone and acridine drugs.
Gláz ET; Tálas M
Arch Virol; 1975; 48(4):375-84. PubMed ID: 1200845
[TBL] [Abstract][Full Text] [Related]
38. Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compounds.
Balakrishnan S; Mester L; Venkataramaniah HN; Bhatia VN
Indian J Lepr; 1985; 57(2):323-8. PubMed ID: 3908578
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
Dhople AM
Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
[TBL] [Abstract][Full Text] [Related]
40. Failure of an interferon inducer to inhibit multiplication of Mycobacterium leprae.
Levy L; Merigan TC
Proc Soc Exp Biol Med; 1970 May; 134(1):87-9. PubMed ID: 4912559
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
